Approval · Notice of Compliance 14136 · 2013
COMPONENT TE-S IMPLANTS: Notice of Compliance 14136
Issued February 18, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14136
- Date
- February 18, 2013
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Transfer of DIN ownership
- Therapeutic class
- Growth promotant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPONENT TE-S IMPLANTS | 02237832 | Dormant |
Medicinal ingredients
- ESTRADIOL 24 MG per IMP
- TRENBOLONE ACETATE 120 MG per IMP